Why Medline Inc.’s (MDLN) Stock Is Down 11.62%
As of Wednesday, August 05, Medline Inc.’s MDLN share price has dipped by 11.62%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Tudor Pop
Michael Rose
Michael Rose
| Share Statistics | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $30,435.3 | $415.8 | 90% |
|
| Shares Out (Mil) | 860.9 | 40.8 | 93% |
|
| Institutional Ownership | 98.2% | 83.6% | 78% |
|
| Float (Mil) | 341.0 | 35.5 | 81% |
|
| Beta | na | 0.88 | na |
|
| Avg Daily Volume (000s) | 7,175 | 329 | 95% |
|
| Price Change (52-week) |
na | 65.6% | na |
|
| Growth | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.8%) | na |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 22 | 17 | 24 | |
| Current EPS | $0.347 | $1.564 | $1.586 | |
| Month Ago EPS | $0.357 | $1.550 | $1.616 | |
| # Rev Up | 4 | 5 | 3 | |
| # Rev Down | 1 | 1 | 2 | |
| Three Months Ago EPS | $0.387 | $1.514 | $1.669 | |
| Year/Year Chg | 402.9% | 9.3% | 27.4% | |
| Financials | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $29,939 | $119 | 94% |
|
| Net Income (TTM) (Mil) | $693 | ($9) | 82% |
|
| EPS (TTM) | $0.799 | ($0.400) | 58% |
|
| Operating Cash Flow (TTM) (Mil) | $1,992 | ($3) | 88% |
|
| Net Cash Flow (TTM) (Mil) | $1,745 | $1 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $12,548 | $23 | 93% |
|
| Enterprise Value (Q1) (Mil) | $47,784 | $376 | 92% |
|
| Valuation | MDLN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.63 | 2.88 | 60% |
|
| P/E | 43.6 | 26.7 | 82% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 25.1% | 58.5% | 28% |
|
| Net Margin | 2.3% | (6.9%) | 39% |
|
| ROA | 1.8% | (13.3%) | 54% |
|
| ROE | 4.9% | (13.3%) | 43% |
|
| Liabilities to Assets | 51.5% | 46.0% | 44% |
|
| F-Score | 5 | 4 | na |
|
Medline Inc. did not pass any screens on 9/8/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors